Margaret Schot

Statistics

Publications

Citations

H-Index

Active since

1998

Affiliations

The Netherlands Cancer Institute(Current)

Slotervaartziekenhuis

Utrecht University

University Medical Center Utrecht

Margaret Schot is an author at The Netherlands Cancer Institute specializing in pharmacology, pharmacokinetics of anticancer drugs, and pharmacokinetics of anticancer agents.

Publications per year

1998–2019

Publications

Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918

C.M.F. Kruijtzer, Jos H. Beijnen, Hilde Rosing et al. · Journal of Clinical Oncology · 2002 · 462 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients

Mila Donker, Marieke E. Straver, Jelle Wesseling et al. · Annals of Surgery · 2014 · 423 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

Jetske M. Meerum Terwogt, W.W. ten Bokkel Huinink, Jan H.M. Schellens et al. · Anti-Cancer Drugs · 2001 · 278 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Coadministration of Cyclosporine Strongly Enhances the Oral Bioavailability of Docetaxel

Mirte M. Malingré, Dick J. Richel, Jos H. Beijnen et al. · Journal of Clinical Oncology · 2001 · 199 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

Jetske M. Meerum Terwogt, Gerard Groenewegen, Dick Pluim et al. · Cancer Chemotherapy and Pharmacology · 2002 · 122 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

1–5 of 20